• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Euro Surveill. Initial surveillance of 2009 influenza A(H1N1) pandemic in the European Union and European Economic Area, April ? September 2009

Giuseppe

Emeritus
Initial surveillance of 2009 influenza A(H1N1) pandemic in the European Union and European Economic Area, April ? September 2009 (Euro Surveill., abstract, edited)


[Source: Eurosurveillance, full text: <cite cite="http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=19740">Eurosurveillance - View Article</cite>. Abstract, edited.]

Eurosurveillance, Volume 15, Issue 49, 09 December 2010

Surveillance and outbreak reports

Initial surveillance of 2009 influenza A(H1N1) pandemic in the European Union and European Economic Area, April ? September 2009

I Devaux 1, P Kreidl 1, P Penttinen 1, Mika Salminen 1, P Zucs 1, A Ammon 1, on behalf of the ECDC influenza surveillance group 2, and the national coordinators for influenza surveillance 3

1. European Centre for Disease Prevention and Control (ECDC) Stockholm, Sweden
2. The members of this group are listed at the end of this article
3. The members of the group are listed at the end of the article

Citation style for this article: Devaux I, Kreidl P, Penttinen P, Salminen M, Zucs P, Ammon A, on behalf of the ECDC influenza surveillance group, and the national coordinators for influenza surveillance. Initial surveillance of 2009 influenza A(H1N1) pandemic in the European Union and European Economic Area, April ? September 2009. Euro Surveill. 2010;15(49):pii=19740. Available online: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=19740

Date of submission: 22 June 2010


European Union (EU) and European Economic Area (EEA) countries reported surveillance data on 2009 pandemic influenza A(H1N1) cases to the European Centre for Disease Prevention and Control (ECDC) through the Early Warning and Response System (EWRS) during the early phase of the 2009 pandemic. We describe the main epidemiological findings and their implications in respect to the second wave of the 2009 influenza pandemic. Two reporting systems were in place (aggregate and case-based) from June to September 2009 to monitor the evolution of the pandemic. The notification rate was assessed through aggregate reports. Individual data were analysed retrospectively to describe the population affected. The reporting peak of the first wave of the 2009 pandemic influenza was reached in the first week of August. Transmission was travel-related in the early stage and community transmission within EU/EEA countries was reported from June 2009. Seventy eight per cent of affected individuals were less than 30 years old. The proportions of cases with complications and underlying conditions were 3% and 7%, respectively. The most frequent underlying medical conditions were chronic lung (37%) and cardio-vascular diseases (15%). Complication and hospitalisation were both associated with underlying conditions regardless of age. The information from the first wave of the pandemic produced a basis to determine risk groups and vaccination strategies before the start of the winter wave. Public health recommendations should be guided by early capture of profiles of affected populations through monitoring of infectious diseases.

-
------<cite cite="http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=19740"></cite>
 
Back
Top Bottom